Compounds > 4-aminopyridine

4-aminopyridine and warfarin

4-aminopyridine has been researched along with warfarin in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baggio, CH; Cipriani, TR; da Silva-Santos, JE; de Souza, LM; Freitas, CS; Graça, C; Marques, MC; Pontarolo, R; Rattmann, YD; Rieck, L; Sassaki, GL1
Anzola, JV; Beauregard, C; Chen, J; Coyle, AR; Gamache, DA; Govek, SP; Hellberg, MR; Hsien, JN; Lerch, JM; Liao, JC; Malecha, JW; Noble, SA; Oshiro, G; Shiau, AK; Staszewski, LM; Thomas, DJ; Yanni, JM1
Alavijeh, MS; Azizian, H; Balalaie, S; Ghalehshahi, HG; Sohbati, HR1

Other Studies

3 other study(ies) available for 4-aminopyridine and warfarin

ArticleYear
In vivo assessment of safety and mechanisms underlying in vitro relaxation induced by Mikania laevigata Schultz Bip. ex Baker in the rat trachea.
    Journal of ethnopharmacology, 2007, Jul-25, Volume: 112, Issue:3

    Topics: 4-Aminopyridine; Acetylcholine; Animals; Brazil; Coumarins; Dose-Response Relationship, Drug; Female; Gas Chromatography-Mass Spectrometry; Glyburide; In Vitro Techniques; Male; Mice; Mikania; Muscle Relaxation; Muscle, Smooth; NG-Nitroarginine Methyl Ester; Oxadiazoles; Plant Extracts; Potassium Channel Blockers; Quinoxalines; Rats; Rats, Wistar; Tetraethylammonium; Toxicity Tests, Acute; Toxicity Tests, Chronic; Trachea

2007
Water-soluble PDE4 inhibitors for the treatment of dry eye.
    Bioorganic & medicinal chemistry letters, 2010, May-01, Volume: 20, Issue:9

    Topics: 4-Aminopyridine; Animals; Anti-Inflammatory Agents; Binding Sites; Computer Simulation; Coumarins; Cyclic Nucleotide Phosphodiesterases, Type 4; Disease Models, Animal; Dry Eye Syndromes; Phosphodiesterase 4 Inhibitors; Rabbits; Rats; Water

2010
Synthesis, CYP 450 evaluation, and docking simulation of novel 4-aminopyridine and coumarin derivatives.
    Archiv der Pharmazie, 2019, Volume: 352, Issue:3

    Topics: 4-Aminopyridine; Central Nervous System Diseases; Coumarins; Cytochrome P-450 Enzyme System; Drug Discovery; Humans; Molecular Docking Simulation; Molecular Structure; Potassium Channels; Protein Binding

2019